Related references
Note: Only part of the references are listed.The Risk-Benefit Profile of Aprotinin Versus Tranexamic Acid in Cardiac Surgery
Keyvan Karkouti et al.
ANESTHESIA AND ANALGESIA (2010)
High-Dose Tranexamic Acid Is Associated with Nonischemic Clinical Seizures in Cardiac Surgical Patients
John M. Murkin et al.
ANESTHESIA AND ANALGESIA (2010)
Multidisciplinary Approach to the Challenge of Hemostasis
Jerrold H. Levy et al.
ANESTHESIA AND ANALGESIA (2010)
Clopidogrel Increases Blood Transfusion and Hemorrhagic Complications in Patients Undergoing Cardiac Surgery
Christine R. Herman et al.
ANNALS OF THORACIC SURGERY (2010)
Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies The RESPOND Study
Paul A. Gurbel et al.
CIRCULATION (2010)
Changes in Inflammatory Biomarkers in Patients Treated With Ticagrelor or Clopidogrel
Steen Husted et al.
CLINICAL CARDIOLOGY (2010)
Premature preoperative discontinuation of antiplatelet drug therapy in cardiovascular risk patients: a preliminary study on the role of P2Y12 receptor monitoring
Helfried Metzler et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2010)
Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y12 receptor antagonist, in healthy subjects
Renli Teng et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Incidence of Dyspnea and Assessment of Cardiac and Pulmonary Function in Patients With Stable Coronary Artery Disease Receiving Ticagrelor, Clopidogrel, or Placebo in the ONSET/OFFSET Study
Robert F. Storey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
A Double-Blind, Randomized Study on Prevention and Existence of a Rebound Phenomenon of Platelets After Cessation of Clopidogrel Treatment
Dirk Sibbing et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to cyp 2c19*2 genotype: first experience in patients
P. A. Gurbel et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Limitations of current therapies to prevent thrombosis: a need for novel strategies
Jean-Etienne Fabre et al.
MOLECULAR BIOSYSTEMS (2010)
Comparison of ticagrelor with clopidogrel in patients with planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
Christopher P. Cannon et al.
LANCET (2010)
Transfusion of red blood cells: the impact on short-term and long-term survival after coronary artery bypass grafting, a ten-year follow-up
Albert H. M. van Straten et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2010)
Effect of clopidogrel on perioperative blood loss and transfusion in coronary artery bypass graft surgery
Akmal Badreldin et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2010)
Advances in Antiplatelet Therapy: Agents in Clinical Development
Dominick J. Angiolillo et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Relation of Body Mass Index to High On-Treatment Platelet Reactivity and of Failed Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients Undergoing Percutaneous Coronary Intervention
Nathalie Bonello-Palot et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Role of Antiplatelet Therapy Across the Spectrum of Patients with Coronary Artery Disease
Deepak L. Bhatt
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Variability in Responsiveness to Oral Antiplatelet Therapy
Dominick J. Angiolillo
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Role of Platelets in Atherothrombosis
Lisa K. Jennings
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Transfusion and Pulmonary Morbidity After Cardiac Surgery
Colleen Koch et al.
ANNALS OF THORACIC SURGERY (2009)
Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis
D. R. McIlroy et al.
BRITISH JOURNAL OF ANAESTHESIA (2009)
Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society
David Fitchett et al.
CANADIAN JOURNAL OF CARDIOLOGY (2009)
The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis
David Henry et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
David N. Juurlink et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Safety and Efficacy of Recombinant Activated Factor VII A Randomized Placebo-Controlled Trial in the Setting of Bleeding After Cardiac Surgery
Ravi Gill et al.
CIRCULATION (2009)
Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary Syndrome
Jeremy A. Rassen et al.
CIRCULATION (2009)
Bedside Evaluation of Thienopyridine Antiplatelet Therapy
Matthew J. Price
CIRCULATION (2009)
Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease The ONSET/OFFSET Study
Paul A. Gurbel et al.
CIRCULATION (2009)
Noncardiac Surgery and Bleeding After Percutaneous Coronary Intervention
Andrew C. Y. To et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2009)
The genetics of antiplatelet drug resistance
G. Feher et al.
CLINICAL GENETICS (2009)
How to manage patients with need for antiplatelet therapy in the setting of (un-)planned surgery
Helge Moellmann et al.
CLINICAL RESEARCH IN CARDIOLOGY (2009)
Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care
Lena M. Napolitano et al.
CRITICAL CARE MEDICINE (2009)
Protocol Based on Thromboelastograph (TEG) Out-Performs Physician Preference Using Laboratory Coagulation Tests to Guide Blood Replacement During and After Cardiac Surgery: A Pilot Study
Andrew J. Westbrook et al.
HEART LUNG AND CIRCULATION (2009)
Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
P. Michael Ho et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease A Meta-analysis of Randomized Trials
Jeffrey S. Berger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
Alan R. Shuldiner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Thromboelastography-Based Transfusion Algorithm Reduces Blood Product Use after Elective CABG: A Prospective Randomized Study
Koray Ak et al.
JOURNAL OF CARDIAC SURGERY (2009)
The Utility of Thromboelastography for Guiding Recombinant Activated Factor VII Therapy for Refractory Hemorrhage After Cardiac Surgery
Marcin Wasowicz et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2009)
Randomized Comparison of Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With High Post-Treatment Platelet Reactivity
Young-Hoon Jeong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Antiplatelet agents used for early intervention in acute coronary syndrome: Myocardial salvage versus bleeding complications
Sary F. Aranki et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Ticagrelor binds to human P2Y(12) independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation
J. J. J. van Giezen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
Gilles Montalescot et al.
LANCET (2009)
Intravenous Platelet Blockade with Cangrelor during PCI.
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Platelet Inhibition with Cangrelor in Patients Undergoing PCI.
Robert A. Harrington et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The link between heightened thrombogenicity and inflammation: Pre-procedure characterization of the patient at high risk for recurrent events after stenting
Paul A. Gurbel et al.
PLATELETS (2009)
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3
Robert F. Storey et al.
PLATELETS (2009)
Upregulation of Phagocyte-Derived Catecholamines Augments the Acute Inflammatory Response
Michael A. Flierl et al.
PLOS ONE (2009)
β2 Adrenoreceptor blockade attenuates the hyperinflammatory response induced by traumatic injury
James Rough et al.
SURGERY (2009)
Antiplatelet drug non responsiveness
Patrick Gladding et al.
AMERICAN HEART JOURNAL (2008)
High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients - A Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis
Amir Lotfi et al.
AMERICAN HEART JOURNAL (2008)
Clopidogrel use and bleeding after coronary artery bypass graft surgery
John Hyting-Jun Kim et al.
AMERICAN HEART JOURNAL (2008)
Comparison of higher clopidogrel loading and maintenance dose to standard dose on platelet function and outcomes after percutaneous coronary intervention using drug-eluting stents
Mohammed Abuzahra et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers
Patrick A. Gladding et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin
Mehmet Akif Duzenli et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Comparison of the Impact of Short (<1 Year) and Long-Term (≥1 Year) Clopidogrel Use Following Percutaneous Coronary Intervention on Mortality
Subhash Banerjee et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery
Andinet M. Mengistu et al.
ANESTHESIA AND ANALGESIA (2008)
An Evaluation of Cyclooxygenase-1 Inhibition Before Coronary Artery Surgery: Aggregometry Versus Patient Self-Reporting
Niels Rahe-Meyer et al.
ANESTHESIA AND ANALGESIA (2008)
Point-of-Care Whole Blood Impedance Aggregometry Versus Classical Light Transmission Aggregometry for Detecting Aspirin and Clopidogrel: The Results of a Pilot Study
Corinna Velik-Salchner et al.
ANESTHESIA AND ANALGESIA (2008)
Coronary artery stents: II. Perioperative considerations and management
Lisa T. Newsome et al.
ANESTHESIA AND ANALGESIA (2008)
Coagulation monitoring: Current techniques and clinical use of viscoelastic point-of-care coagulation devices
Michael T. Ganter et al.
ANESTHESIA AND ANALGESIA (2008)
Coronary artery stents: Part I. Evolution of percutaneous coronary intervention
Lisa T. Newsome et al.
ANESTHESIA AND ANALGESIA (2008)
Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents
Jennifer A. Rabbitts et al.
ANESTHESIOLOGY (2008)
Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention
Gregory A. Nuttall et al.
ANESTHESIOLOGY (2008)
The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass
Mike Reinhoefer et al.
BLOOD COAGULATION & FIBRINOLYSIS (2008)
American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
Jack Hirsh et al.
CHEST (2008)
Antithrombotic therapy for peripheral artery occlusive disease
Michael Sobel et al.
CHEST (2008)
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes
Robert A. Harrington et al.
CHEST (2008)
Antithrombotic and thrombolytic therapy for ischemic stroke
Gregory W. Albers et al.
CHEST (2008)
The primary and secondary prevention of coronary artery disease
Richard C. Becker et al.
CHEST (2008)
Antithrombotic therapy in atrial fibrillation
Daniel E. Singer et al.
CHEST (2008)
The perioperative management of antithrombotic therapy
James. D. Douketis et al.
CHEST (2008)
Acute ST-segment elevation myocardial infarction
Shaun G. Goodman et al.
CHEST (2008)
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38
Stephen D. Wiviott et al.
CIRCULATION (2008)
Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid Determinants and Effect on Cardiovascular Risk
John W. Eikelboom et al.
CIRCULATION (2008)
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
Deepak L. Bhatt et al.
CIRCULATION (2008)
Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: A randomized, single-blind, 30-day trial
Victor L. Serebruany et al.
CLINICAL THERAPEUTICS (2008)
The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies
Jack C. J. Sun et al.
EUROPEAN HEART JOURNAL (2008)
Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients
Marie Lordkipanidze et al.
EUROPEAN HEART JOURNAL (2008)
Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial
Sabina A. Murphy et al.
EUROPEAN HEART JOURNAL (2008)
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study
Dominick J. Angiolillo et al.
EUROPEAN HEART JOURNAL (2008)
Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent
Norbert Zimmermann et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2008)
Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129 314 patients
Victor L. Serebruany et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome
P. Michael Ho et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel
David S. Small et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Type 3 Phosphodiesterase Inhibitors May Be Protective Against Cerebrovascular Events in Patients with Claudication
William M. Stone et al.
Journal of Stroke & Cerebrovascular Diseases (2008)
Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents
Anna Maria Gori et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention
Elliott M. Antman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Impact of Clopidogrel in Patients With Acute Coronary Syndromes Requiring Coronary Artery Bypass Surgery A Multicenter Analysis
Jeffrey S. Berger et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: A multicenter randomized prospective study
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo
David Erlinge et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin
Martine Gilard et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)
William R. Hiatt et al.
JOURNAL OF VASCULAR SURGERY (2008)
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
Stephen D. Wiviott et al.
LANCET (2008)
Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study
Yining Huang et al.
LANCET NEUROLOGY (2008)
Cardiovascular outcomes after a change in prescription policy for clopidogrel
Cynthia A. Jackevicius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The use of the VerifyNow system to monitor antiplatelet therapy: A review of the current evidence
J. W. van Werkum et al.
PLATELETS (2008)
Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects
Christopher D. Payne et al.
PLATELETS (2008)
Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting
A. Simon Pickard et al.
PHARMACOTHERAPY (2008)
Effect of Atorvastatin on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Subjects
Nagy A. Farid et al.
PHARMACOTHERAPY (2008)
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack
Robert J. Adams et al.
STROKE (2008)
Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness
Pierre Fontana et al.
THROMBOSIS RESEARCH (2008)
Aspirin resistance and risk of cardiovascular morbidity: systematic review and meta-analysis
George Krasopoulos et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Prasugrel achieves greater and faster P2Y(12) receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
Lars Wallentin et al.
EUROPEAN HEART JOURNAL (2008)
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention - The prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation-thrombolysis in myocardial infarction 44 trial
Stephen D. Wiviott et al.
CIRCULATION (2007)
Prasugrel: A novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile
Joseph A. Jakubowski et al.
CARDIOVASCULAR DRUG REVIEWS (2007)
The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients - An analysis from the aspirin-induced platelet effect (ASPECT) study
Joseph DiChiara et al.
DIABETES (2007)
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel
J. T. Brandt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Safety, tolerability, and initial efficacy of AZD6140, the first reversivle oral adenosine diphosphate receptor antagonist, compared with clopidigrel, in patients with non-ST-segment elevation acute coronary syndrome - Primary results of the DISPERSE-2 trial
Christopher P. Cannon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Inhibition of platelet aggregation by AZD6140, A reversible oral P2Y12 receptor antagonist, compared with clopidogral in patients with acute coronary syndrome
Robert F. Storey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Effect of cilostazol on in-stent neointimal hyperplasia after coronary artery stenting - A quantitative coronary angiography and volumetric intravascular ultrasound study
Pil-Ki Min et al.
CIRCULATION JOURNAL (2007)
Clopidogrel is safe early after on- and off-pump coronary artery bypass surgery
Vincent Chan et al.
JOURNAL OF CARDIAC SURGERY (2007)
Characterization of human cytochrome p450 enzymes involved in the metabolism of cilostazol
Masahiro Hiratsuka et al.
DRUG METABOLISM AND DISPOSITION (2007)
Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction:: Results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial
Adam B. Greenbaum et al.
AMERICAN HEART JOURNAL (2007)
Greater inhibition of platelet aggregation and reduced response variability with prasugrel versus clopidogrel: An integrated analysis
Govinda J. Weerakkody et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2007)
Clopidogrel non responsiveness in patients undergoing percutaneous coronary intervention with stenting: A systematic review and meta-analysis
Jaapjan D. Snoep et al.
AMERICAN HEART JOURNAL (2007)
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial
Jacqueline Saw et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Comparison of speed of onset of platelet inhibition after loading doses of clopidogrel versus prasugrel in healthy volunteers and correlation with responder status
Govinda J. Weerakkody et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Risk factors for red cell transfusion in adults undergoing coronary artery bypass surgery: a systematic review
N. Shehata et al.
VOX SANGUINIS (2007)
A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease
Marie Lordkipanidze et al.
EUROPEAN HEART JOURNAL (2007)
The role of recombinant factor VIIa in on-pump cardiac surgery: Proceedings of the Canadian Consensus Conference
Keyvan Karkouti et al.
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2007)
The disposition of prasugrel, a novel thienopyridine, in humans
Nagy A. Farid et al.
DRUG METABOLISM AND DISPOSITION (2007)
Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection
M. Cattaneo
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
A review of aspirin resistance; definition, possible mechanisms, detection with platelet function tests, and its clinical outcomes
Burak Pamukcu
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2007)
Coronary artery stents and non-cardiac surgery
G. M. Howard-Alpe et al.
BRITISH JOURNAL OF ANAESTHESIA (2007)
Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently
N. A. Farid et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans
Joseph A. Jakubowski et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Use of nonsteroidal Antiinflammatory drugs an update for clinicians - A scientific statement from the American Heart Association
Elliott M. Antman et al.
CIRCULATION (2007)
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:: data from a large two-institutional cohort study
Joost Daemen et al.
LANCET (2007)
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians
Cindy L. Grines et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2007)
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease - Results of the Optimizing antiPlatelet Therapy In diabetes MellitUS (OPTIMUS) study
Dominick J. Angiolillo et al.
CIRCULATION (2007)
Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review
Marcel M. C. Hovens et al.
AMERICAN HEART JOURNAL (2007)
Involvement of alpha(1)-acid glycoprotein in inter-individual variation of disposition kinetics of ropivacaine following epidural infusion in off-pump coronary artery bypass grafting
Koichi Yokogawa et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Dyspnoea after antiplatelet agents: the AZD6140 controversy
V. L. Serebruany et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease - A meta-analysis of Randomized trials
Thomas J. Helton et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2007)
Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease
Steven R. Steinhubl et al.
VASCULAR MEDICINE (2007)
Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial
V. L. Serebruany et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials
Anthony A. Bavry et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Aspirin resistance:: Truth or dare
Marie Lordkipanidze et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Critical pathways using platelet testing to potentially optimize the use of oral antiplatelet therapy
Christopher P. Cannon et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Impact of P-glycoprotein on clopidogrel absorption
Dirk Taubert et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events
Rossella Marcucci et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Resistance to antiplatelet drugs
Alan D. Michelson et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2006)
Cytochrorne P4502C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
Jean-Sebastien Hulot et al.
BLOOD (2006)
A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention
James M. Brophy et al.
AMERICAN HEART JOURNAL (2006)
Chronic β-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress
Aihua Hu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1-and cyclooxygenase-2-independent pathway - A 700-patient study of aspirin resistance
Andrew L. Frelinger et al.
CIRCULATION (2006)
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement results from the PREMIER registry
John A. Spertus et al.
CIRCULATION (2006)
Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel
Jung-Won Suh et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
Patricia M. Kearney et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Platelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO study
V. L. Serebruany et al.
POSTGRADUATE MEDICAL JOURNAL (2006)
The human intestinal cytochrome P450 pie
MF Paine et al.
DRUG METABOLISM AND DISPOSITION (2006)
Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease
T Jernberg et al.
EUROPEAN HEART JOURNAL (2006)
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis:: a double-blind comparison to clopidogrel with aspirin
S Husted et al.
EUROPEAN HEART JOURNAL (2006)
Cangrelor for treatment of coronary thrombosis
SE Fugate et al.
ANNALS OF PHARMACOTHERAPY (2006)
Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450
JLF Rehmel et al.
DRUG METABOLISM AND DISPOSITION (2006)
Aspirin and clopidogrel resistance
ED Michos et al.
MAYO CLINIC PROCEEDINGS (2006)
Aspirin and clopidogrel resistance: an emerging clinical entity
TH Wang et al.
EUROPEAN HEART JOURNAL (2006)
Determination of clopidogrel resistance by whole blood platelet aggregometry and inhibitors of the P2Y12 receptor
BT Ivandic et al.
CLINICAL CHEMISTRY (2006)
Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention:: Results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial
AB Greenbaum et al.
AMERICAN HEART JOURNAL (2006)
Epidural haematoma after a combined spinal-epidural anaesthetic in a patient treated with clopidogrel and dalteparin
NLK Tam et al.
BRITISH JOURNAL OF ANAESTHESIA (2006)
Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention - The role of dual drug resistance
EI Lev et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Pharmacogeneties of antithrombotic drugs
D. Tassies
CURRENT PHARMACEUTICAL DESIGN (2006)
Thienopyridines and statins: Assessing a potential drug-drug interaction
H. Neubauer et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Aspirin resistance: Definitions, mechanisms, prevalence, and, clinical significance
L Macchi et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Use of the platelet function analyser (PFA-100®) to quantify the effect of low dose aspirin in patients with ischaemic heart disease
M Coakley et al.
ANAESTHESIA (2005)
Proton pump inhibitor formulary considerations in the acutely ill. part 2: Clinical efficacy, safety, and economics
JW Devlin et al.
ANNALS OF PHARMACOTHERAPY (2005)
Dipyridamole, an underestimated vascular protective drug
W Schaper
CARDIOVASCULAR DRUGS AND THERAPY (2005)
The efficacy of preanesthetic proton pump inhibitor treatment for patients on long-term H2 antagonist therapy
K Hirota et al.
ANESTHESIA AND ANALGESIA (2005)
Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole
A Gamboa et al.
STROKE (2005)
Resistance to aspirin in patients after coronary artery bypass grafting is transient - Impact on the monitoring of aspirin antiplatelet therapy
J Golanski et al.
THERAPEUTIC DRUG MONITORING (2005)
Dipyridamole bioavailability in subjects with reduced gastric acidity
H Derendorf et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Randomized comparison of Prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention -: Results of the joint utilization of medications to block platelets optimally (JUMBO)-TIMI 26 trial
SD Wiviott et al.
CIRCULATION (2005)
Aspirin resistance: Position paper of the working group on aspirin resistance
AD Michelson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention
W Hochholzer et al.
CIRCULATION (2005)
The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting
PA Gurbel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Low-dose aspirin for secondary cardiovascular prevention -: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation -: review and meta-analysis
W Burger et al.
JOURNAL OF INTERNAL MEDICINE (2005)
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects
ML Capone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction
KA Schwartz et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Pharmacology of CS-747 (Prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity
Y Niitsu et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2005)
Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery
NA Nussmeier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Narrative review: Aspirin resistance and its clinical implications
S Sanderson et al.
ANNALS OF INTERNAL MEDICINE (2005)
Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study
DJ Graham et al.
LANCET (2005)
Variability in platelet responsiveness to clopidogrel among 544 individuals
VL Serebruany et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke
J Weinberger
DRUGS (2005)
Effect of increasing doses of aspirin on platelet function as measured by PFA-100 in patients with diabetes
A Abaci et al.
THROMBOSIS RESEARCH (2005)
Dipyridamole for preventing recurrent ischemic stroke and other vascular events - A meta-analysis of individual patient data from randomized controlled trials
J Leonardi-Bee et al.
STROKE (2005)
Clopidogrel did not inhibit platelet function early after coronary bypass surgery: A prospective randomized trial
E Lim et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2004)
Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting
LQ Chen et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2004)
Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: A meta-analysis of randomized trials
MD Schleinitz et al.
AMERICAN HEART JOURNAL (2004)
Risk of bleeding complications with antiplatelet agents: Meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials
VL Serebruany et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
S Matetzky et al.
CIRCULATION (2004)
Indirect comparison meta-analysis of aspirin therapy after coronary surgery
E Lim et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
An update on aspirin in the primary prevention of cardiovascular disease
RS Eidelman et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs
T Kurth et al.
CIRCULATION (2003)
Clopidogrel for coronary stenting - Response variability, drug resistance, and the effect of pretreatment platelet reactivity
PA Gurbel et al.
CIRCULATION (2003)
Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270
ZR Ding et al.
BLOOD (2003)
Effect of ibuprofen on cardioprotective effect of aspirin
TM MacDonald et al.
LANCET (2003)
Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation - A new drug-drug interaction
WC Lau et al.
CIRCULATION (2003)
Limited influence of P-glycoprotein on small-intestinal absorption of cilostazol, a high absorptive permeability drug
H Toyobuku et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease
RF Storey et al.
PLATELETS (2002)
Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events
SM Weisman et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Aspirin and mortality from coronary bypass surgery
DT Mangano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use
KC Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Safety profile and tolerability of intravenous AR-C69931MX, a new antiplatelet drug, in unstable angina pectoris and non-Q-wave myocardial infarction
F Jacobsson et al.
CLINICAL THERAPEUTICS (2002)
Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy
WR Hiatt
JOURNAL OF INTERNAL MEDICINE (2002)
Parenteral ketorolac and risk of myocardial infarction
SE Kimmel et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2002)
The pharmacology of cilostazol
K Schror
DIABETES OBESITY & METABOLISM (2002)
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
F Catella-Lawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Vascular bed-specific hemostasis: Role of endothelium in pathogenesis
WC Aird
CRITICAL CARE MEDICINE (2001)
Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease
P Robless et al.
BRITISH JOURNAL OF SURGERY (2001)
Drug therapy - Medical treatment of peripheral arterial disease and claudication.
WR Hiatt
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis
S Derry et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina
F Cipollone et al.
CIRCULATION (2000)
Thrombotic thrombocytopenic purpura associated with clopidogrel.
CL Bennett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties
A Sugidachi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Cirrhosis does not affect the pharmacokinetics and pharmacodynamics of clopidogrel
PH Slugg et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease:: a meta-analysis
B Girolami et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2000)
Share Paper
